Pulmatrix Inc. is a biopharmaceutical company that develops innovative inhaled therapies for serious respiratory diseases. Their proprietary iSPERSE technology enables targeted delivery of drugs to the lungs, offering improved efficacy and reduced side effects. With a strong pipeline and strategic partnerships, Pulmatrix is poised for success in transforming respiratory care.
